TLR4 and colitis: Recently, alpinetin was shown to provide protection against DSS-induced colitis in mice via blockade of toll-like receptor-4 (TLR4)/NF-kB signaling pathway and NOD-like receptor protein 3 (NLRP3) inflammasome activation (He et al., 2016).